Key result
Thrombomodulin is a specific and highly sensitive marker for angiosarcomas compared with FVIII-RAG or UEA-I, whereas UEA-I is more sensitive for benign vascular tumors.
Why the study?
Is thrombomodulin a more sensitive and specific marker for vascular tumors compared to Factor VIII and Ulex europaeus I lectin?
Observational
Is thrombomodulin a more sensitive and specific marker for vascular tumors compared to Factor VIII and Ulex europaeus I lectin?
Thrombomodulin serves as a highly sensitive and specific immunohistochemical marker for diagnosing angiosarcomas.
Answers are grounded in this paper and cite their sources.
Thrombomodulin may aid angiosarcoma diagnosis in select pathology cases; leaves open prospective validation before routine adoption.
Thrombomodulin (TM) is a newly described endothelial cell-associated protein that functions as a potent natural anticoagulant by converting thrombin from a procoagulant protease to an anticoagulant. Various vascular tumors were characterized with immunoperoxidase staining with the use of a polyclonal anti-TM serum. The staining patterns of TM were compared with those of Factor VIII-related antigen (FVIII-RAG) and Ulex europaeus agglutinin-I (UEA-I), which have been used as markers for endothelial cells. The results showed that TM is a specific and a highly sensitive marker for angiosarcomas in comparison with FVIII-RAG or UEA-I. In contrast, UEA-I is more sensitive for benign vascular tumors than TM or FVIII-RAG. The other mesenchymal tumors of nonvascular origin showed negative staining for three endothelial markers. These results indicate that TM is a new specific and sensitive tool for the diagnosis of angiosarcomas.
No takes yet. Share an insight, caveat, or question.
Yonezawa et al. (1987) conducted an observational in Vascular tumors. Thrombomodulin (TM) staining vs. Factor VIII-related antigen (FVIII-RAG) and Ulex europaeus agglutinin-I (UEA-I) was evaluated on Sensitivity and specificity for vascular tumors. Thrombomodulin is a specific and highly sensitive marker for angiosarcomas compared with FVIII-RAG or UEA-I, whereas UEA-I is more sensitive for benign vascular tumors.
Synapse has enriched 10 related papers. Consider them for comparative context: